10-Q quarterly report · filed Oct 21, 2026

Intuitive Surgical (ISRG) Q3 2026 10-Q Quarterly Report

Short answer

Intuitive Surgical (ISRG) filed its Q3 2026 10-Q quarterly report on Oct 21, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3.0B (up 21.7% year over year) with net income of $523M.

Q3 2026 key financials · XBRL

Revenue
$3.0B
+21.7% YoY · +5.4% QoQ
Net income
$523M
−25.8% YoY · −36.1% QoQ
Operating margin
19.4%
Gross margin
68.4%
EPS (diluted)
$1.50
−23.1% YoY · −34.5% QoQ

Source: XBRL data from the Intuitive Surgical (ISRG) Q3 2026 10-Q on SEC EDGAR. USD.

Intuitive Surgical Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $3.05B, up 22% YoY from $2.51B, driven by systems revenue growth of 30% to $769M
  • Gross margin 68.4% vs 66.4% YoY; product margin 68.9% vs 66.8%, service margin 65.4% vs 63.8%
  • Best segment systems revenue $769M, up 30%; worst instruments and accessories still grew 18% to $1.80B
  • Cash, equivalents, and investments $6.80B vs $9.03B at December 31, 2025; $2.94B spent on share repurchases
  • Outlook: 2027 pricing actions expected to reduce instruments revenue per procedure 3% to 5%; China pricing reductions begin Q4 2026

Risk Factors

  • New geopolitical risk: Iran conflict added to Middle East disruptions affecting commodities, supply constraints, and liquidity
  • Market risk: tariffs and export controls may increase raw-material and finished-goods costs
  • Financial risk: cash and equivalents declined to $2,978.1 million from $3,368.0 million
  • Regulatory risk: ASU 2025-05 adoption introduced expected-credit-loss estimation changes, without material financial impact

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Intuitive Surgical quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.